Post-operative platelet count profile: The most reliable tool for identifying patients with true heparin-induced thrombocypenia after cardiac surgery

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 1, 2010, Pages 27-29

  Gruel, Y ^a   Pouplard, C ^b  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; DANAPAROID; HEPARIN; IMMUNOGLOBULIN G; LEPIRUDIN; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4;

ANTIBODY DETECTION; CARDIOPULMONARY BYPASS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MEDICAL DECISION MAKING; NOTE; OPERATION DURATION; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN SECRETION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ANTIBODIES; ANTICOAGULANTS; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; PLATELET ACTIVATION; PLATELET COUNT; PLATELET FACTOR 4; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; THROMBOCYTOPENIA; TIME FACTORS;

EID: 73049083595     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03646.x     Document Type: Note

References (13)

1. Amiral J, Bridey F, Dreyfus M, Vissac A, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992, 68:95-6.
2. Warkentin T, Warkentin T, Greinacher A. Clinical picture of heparin-induced thrombocytopenia. Heparin-Induced Thrombocytopenia 2007, 21-66. In, eds, 4th edn, New York, Informa Healthcare USA
3. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006, 4:759-65.
4. Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 1997, 99:273-80.
5. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997, 95:1242-6.
6. Pouplard C, May MA, Iochmann S, Amiral J, Vissac AM, Marchand M, Gruel Y. Antibodies to platelet factor 4 - heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin - clinical implications for heparin-induced thrombocytopenia. Circulation 1999, 99:2530-6.
7. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000, 96:1703-8.
8. Pouplard C, May M, Regina S, Maakaroun A, Fusciardi J, Gruel Y. Changes in the platelet count after cardiopulmonary bypass can efficiently predict the development of pathogenic heparin-dependent antibodies. Blood 2002, abstract: 16a-7a
9. Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 2005, 128:837-41.
10. Lillo-Le Louet A, Boutouyrie P, Alhenc-Gelas M, Le Beller C, Gautier I, Aiach M, Lasne D. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2004, 2:1882-8.
11. Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert H-G, Warkentin TE, Greinacher A. Early-onset and persisting thrombocytopenia is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost 2009, 8:30-6.
12. Selleng S, Selleng K, Wollert HG, Muellejans B, Lietz T, Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost 2008, 6:428-35.
13. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4- dependent enzyme-immunoassays. J Thromb Haemost 2008, 6:1304-12.